ATE88343T1 - Anxiolytisches praeparat. - Google Patents

Anxiolytisches praeparat.

Info

Publication number
ATE88343T1
ATE88343T1 AT87309984T AT87309984T ATE88343T1 AT E88343 T1 ATE88343 T1 AT E88343T1 AT 87309984 T AT87309984 T AT 87309984T AT 87309984 T AT87309984 T AT 87309984T AT E88343 T1 ATE88343 T1 AT E88343T1
Authority
AT
Austria
Prior art keywords
anxiolytic
preparations
medetomidine
useful
treatment
Prior art date
Application number
AT87309984T
Other languages
English (en)
Inventor
Risto Lammintausta
Raimo Virtanen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Application granted granted Critical
Publication of ATE88343T1 publication Critical patent/ATE88343T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
AT87309984T 1986-11-11 1987-11-11 Anxiolytisches praeparat. ATE88343T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI864570A FI864570A0 (fi) 1986-11-11 1986-11-11 Terapeutiskt anvaendbar foerening.
EP87309984A EP0270267B1 (de) 1986-11-11 1987-11-11 Anxiolytisches Präparat

Publications (1)

Publication Number Publication Date
ATE88343T1 true ATE88343T1 (de) 1993-05-15

Family

ID=8523472

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87309984T ATE88343T1 (de) 1986-11-11 1987-11-11 Anxiolytisches praeparat.

Country Status (12)

Country Link
US (1) US4783477A (de)
EP (1) EP0270267B1 (de)
JP (1) JPS63135330A (de)
AT (1) ATE88343T1 (de)
AU (1) AU587144B2 (de)
DE (1) DE3785549T2 (de)
DK (1) DK175040B1 (de)
ES (1) ES2054687T3 (de)
FI (1) FI864570A0 (de)
HU (1) HU201472B (de)
IE (1) IE60121B1 (de)
ZA (1) ZA878055B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5344840A (en) * 1988-02-29 1994-09-06 Orion-Yhtyma Oy 4-substituted imidazole derivatives useful in perioperative care
US5124157A (en) 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
GB2256135B (en) 1991-05-31 1995-01-18 Orion Yhtymae Oy Transdermal administration of 4-substituted imidazoles
GB9111732D0 (en) 1991-05-31 1991-07-24 Orion Yhtymae Oy The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs
US5457100A (en) * 1991-12-02 1995-10-10 Daniel; David G. Method for treatment of recurrent paroxysmal neuropsychiatric
PT1036065E (pt) * 1997-12-04 2004-09-30 Allergan Inc Derivados de imidazol substituidos com actividade do tipo agonista nos receptores alfa 2b ou 2b/2c adrenergicos
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
MX368880B (es) * 2012-10-15 2019-10-21 Orion Corp Dexmedetomidina y medetomidina para su uso en el alivio de la aversión al ruido en un animal.
KR101891185B1 (ko) 2013-10-07 2018-08-24 테이코쿠 팔마 유에스에이, 인코포레이티드 비진정량의 덱스메데토미딘의 경피 전달을 위한 방법 및 조성물
RU2646512C2 (ru) 2013-10-07 2018-03-05 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Устройства для трансдермальной доставки дексмедетомидина и способы их применения
TWI709417B (zh) 2013-10-07 2020-11-11 美商帝國製藥美國股份有限公司 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物
KR20190060007A (ko) 2016-10-31 2019-05-31 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치를 이용한 통증을 관리하는 방법
CN110072524A (zh) * 2016-12-13 2019-07-30 奥赖恩公司 用于治疗狗的分离焦虑的右美托咪定或美托咪定

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1560271A (en) * 1977-01-14 1980-02-06 Joullie International Sa Therapeutically useful m-trifluoromethylphenylpiperazine derivatives
US4147872A (en) * 1977-09-13 1979-04-03 Pfizer Inc. 3-[2-Hydroxy-4-(substituted)-phenyl]azacycloalkanes and derivatives thereof as analgesic agents and intermediates therefor
ZA815327B (en) * 1980-08-05 1982-07-28 Hoffmann La Roche Benzazepine derivatives
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
US4575510A (en) * 1983-02-17 1986-03-11 Merrell Dow Pharmaceuticals Inc. Method of alleviating withdrawal symptoms
NZ208554A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
NL8500047A (nl) * 1985-01-09 1986-08-01 Philips Nv Televisie ontvanger met teletext-decodeerschakeling en paginanummergeheugen.

Also Published As

Publication number Publication date
DE3785549T2 (de) 1993-09-09
DK496687D0 (da) 1987-09-22
US4783477A (en) 1988-11-08
EP0270267A3 (en) 1990-07-04
DK175040B1 (da) 2004-05-10
ZA878055B (en) 1988-04-26
HU201472B (en) 1990-11-28
IE873015L (en) 1988-05-11
ES2054687T3 (es) 1994-08-16
EP0270267B1 (de) 1993-04-21
EP0270267A2 (de) 1988-06-08
IE60121B1 (en) 1994-06-01
HUT45399A (en) 1988-07-28
DK496687A (da) 1988-05-12
JPS63135330A (ja) 1988-06-07
FI864570A0 (fi) 1986-11-11
AU7826987A (en) 1988-05-12
AU587144B2 (en) 1989-08-03
DE3785549D1 (de) 1993-05-27

Similar Documents

Publication Publication Date Title
IT8621411A0 (it) Padiglione smontabile particolarmente per il ricovero temporaneo di persone.
FI874671A0 (fi) Anordning foer foerhindrande av laeckage i tryckledningar.
DE3785549D1 (de) Anxiolytisches praeparat.
DK130387D0 (da) Transglutaminase inhibitorer
DE3780618D1 (de) Verwendung von buspiron zur verbesserung des kurzzeitgedaechtnisses.
IT1200852B (it) Procedimento e dispositivo per l'alimentazione di elementida montare
DE3484549D1 (de) (3-amino-1h-pyrazol-4-yl)(aryl)ketone.
FI850781L (fi) Foerfarande foer framstaellning av av l-karnitin pao mikrobiologiskt saett.
IT1211197B (it) Pannelli dispositivo per l alimentazione di
DK472688A (da) Anvendelse af bezafibrat til behandling af diabetes
ATE92318T1 (de) Isolierung von castanospermin und dessen verwendung als antidiabetisches heilmittel.
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
FI873125A0 (fi) Foerfarande foer framstaellning av 5,6-substituerade 2,4-kinazolindiaminer samt nya mellanprodukter.
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
ATE79255T1 (de) Wirkstoffe zur verhuetung von tumormetastasen.
GB8616889D0 (en) Source of power
IT1217541B (it) Procedimento per il comando di un orditoio e orditoio per l'esecuzione del procedimento
DE3863093D1 (de) Sulfosuccinamidsaeuren von polyoxypropylendiaminen und ihre verwendung als emulgatoren.
TR24449A (tr) Tiyazinol tuerevleri hazirlanmalarina mahsus usul v ve fungusid olarak kullanimi
NO862454L (no) Fremgangsmaate for behandling av peroxydblekeavluter.
IT8603003V0 (it) Crick martinetto del 2000
FI871737A0 (fi) Kraftanlaeggning med foerbraenning i en fluidiserad baedd.
SU1405143A1 (ru) Способ лечения острых нарушений мозгового кровообращения
ATE74755T1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-am no-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time